157 related articles for article (PubMed ID: 19029420)
1. Managing symptoms among patients with breast cancer during chemotherapy: results of a two-arm behavioral trial.
Given CW; Sikorskii A; Tamkus D; Given B; You M; McCorkle R; Champion V; Decker D
J Clin Oncol; 2008 Dec; 26(36):5855-62. PubMed ID: 19029420
[TBL] [Abstract][Full Text] [Related]
2. Response analysis for multiple symptoms revealed differences between arms of a symptom management trial.
Sikorskii A; Given CW; You M; Jeon S; Given BA
J Clin Epidemiol; 2009 Jul; 62(7):716-24. PubMed ID: 19124223
[TBL] [Abstract][Full Text] [Related]
3. Differential symptom reporting by mode of administration of the assessment: automated voice response system versus a live telephone interview.
Sikorskii A; Given CW; Given B; Jeon S; You M
Med Care; 2009 Aug; 47(8):866-74. PubMed ID: 19584761
[TBL] [Abstract][Full Text] [Related]
4. Telephone interventions for symptom management in adults with cancer.
Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
[TBL] [Abstract][Full Text] [Related]
5. Symptom management for cancer patients: a trial comparing two multimodal interventions.
Sikorskii A; Given CW; Given B; Jeon S; Decker V; Decker D; Champion V; McCorkle R
J Pain Symptom Manage; 2007 Sep; 34(3):253-64. PubMed ID: 17618080
[TBL] [Abstract][Full Text] [Related]
6. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
[TBL] [Abstract][Full Text] [Related]
7. Analyzing symptom management trials: the value of both intention-to-treat and per-protocol approaches.
Given B; Given CW; Sikorskii A; You M; McCorkle R; Champion V
Oncol Nurs Forum; 2009 Nov; 36(6):E293-302. PubMed ID: 19887342
[TBL] [Abstract][Full Text] [Related]
8. Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer: A Randomized Clinical Trial.
Heery CR; Ibrahim NK; Arlen PM; Mohebtash M; Murray JL; Koenig K; Madan RA; McMahon S; Marté JL; Steinberg SM; Donahue RN; Grenga I; Jochems C; Farsaci B; Folio LR; Schlom J; Gulley JL
JAMA Oncol; 2015 Nov; 1(8):1087-95. PubMed ID: 26291768
[TBL] [Abstract][Full Text] [Related]
9. Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer.
Geels P; Eisenhauer E; Bezjak A; Zee B; Day A
J Clin Oncol; 2000 Jun; 18(12):2395-405. PubMed ID: 10856099
[TBL] [Abstract][Full Text] [Related]
10. Symptom response analysis of a randomized controlled trial of reflexology for symptom management among women with advanced breast cancer.
Sikorskii A; Niyogi PG; Victorson D; Tamkus D; Wyatt G
Support Care Cancer; 2020 Mar; 28(3):1395-1404. PubMed ID: 31267277
[TBL] [Abstract][Full Text] [Related]
11. Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99.
Pagani O; Klingbiel D; Ruhstaller T; Nolè F; Eppenberger S; Oehlschlegel C; Bernhard J; Brauchli P; Hess D; Mamot C; Munzone E; Pestalozzi B; Rabaglio M; Aebi S; Ribi K; Rochlitz C; Rothgiesser K; Thürlimann B; von Moos R; Zaman K; Goldhirsch A;
Ann Oncol; 2017 Feb; 28(2):305-312. PubMed ID: 27998961
[TBL] [Abstract][Full Text] [Related]
12. The relationship between symptom severity and symptom interference, education, age, marital status, and type of chemotherapy treatment in Israeli women with early-stage breast cancer.
Prigozin A; Uziely B; Musgrave CF
Oncol Nurs Forum; 2010 Nov; 37(6):E411-8. PubMed ID: 21059574
[TBL] [Abstract][Full Text] [Related]
13. Prospective longitudinal evaluation of a symptom cluster in breast cancer.
Sanford SD; Beaumont JL; Butt Z; Sweet JJ; Cella D; Wagner LI
J Pain Symptom Manage; 2014 Apr; 47(4):721-30. PubMed ID: 23880589
[TBL] [Abstract][Full Text] [Related]
14. A phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer: results of the ERASME 3 study.
Cassier PA; Chabaud S; Trillet-Lenoir V; Peaud PY; Tigaud JD; Cure H; Orfeuvre H; Salles B; Martin C; Jacquin JP; Agostini C; Guastalla JP; Pérol D; Bachelot T
Breast Cancer Res Treat; 2008 May; 109(2):343-50. PubMed ID: 17611792
[TBL] [Abstract][Full Text] [Related]
15. Impact of chemotherapy on symptoms and symptom clusters in postmenopausal women with breast cancer prior to aromatase inhibitor therapy.
Li H; Sereika SM; Marsland AL; Conley YP; Bender CM
J Clin Nurs; 2019 Dec; 28(23-24):4560-4571. PubMed ID: 31469461
[TBL] [Abstract][Full Text] [Related]
16. A Nurse-Led Care Program for Breast Cancer Patients in a Chemotherapy Day Center: A Randomized Controlled Trial.
Lai XB; Ching SSY; Wong FKY; Leung CWY; Lee LH; Wong JSY; Lo YF
Cancer Nurs; 2019; 42(1):20-34. PubMed ID: 28926349
[TBL] [Abstract][Full Text] [Related]
17. Accelerated-intensified cyclophosphamide, epirubicin, and fluorouracil (CEF) compared with standard CEF in metastatic breast cancer patients: results of a multicenter, randomized phase III study of the Italian Gruppo Oncologico Nord-Ouest-Mammella Inter Gruppo Group.
Del Mastro L; Venturini M; Lionetto R; Carnino F; Guarneri D; Gallo L; Contu A; Pronzato P; Vesentini L; Bergaglio M; Comis S; Rosso R
J Clin Oncol; 2001 Apr; 19(8):2213-21. PubMed ID: 11304774
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of a home care nursing program in the symptom management of patients with colorectal and breast cancer receiving oral chemotherapy: a randomized, controlled trial.
Molassiotis A; Brearley S; Saunders M; Craven O; Wardley A; Farrell C; Swindell R; Todd C; Luker K
J Clin Oncol; 2009 Dec; 27(36):6191-8. PubMed ID: 19917849
[TBL] [Abstract][Full Text] [Related]
19. Virtual reality: a distraction intervention for chemotherapy.
Schneider SM; Hood LE
Oncol Nurs Forum; 2007 Jan; 34(1):39-46. PubMed ID: 17562631
[TBL] [Abstract][Full Text] [Related]
20. Trastuzumab plus anastrozole versus anastrozole alone for the treatment of postmenopausal women with human epidermal growth factor receptor 2-positive, hormone receptor-positive metastatic breast cancer: results from the randomized phase III TAnDEM study.
Kaufman B; Mackey JR; Clemens MR; Bapsy PP; Vaid A; Wardley A; Tjulandin S; Jahn M; Lehle M; Feyereislova A; Révil C; Jones A
J Clin Oncol; 2009 Nov; 27(33):5529-37. PubMed ID: 19786670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
